相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cognitive training modifies disease symptoms in a mouse model of Huntington's disease
Emma Yhnell et al.
EXPERIMENTAL NEUROLOGY (2016)
Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease
Jean-Pascal Morin et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Inhibition of Histone Deacetylase 3 Restores Amyloid-beta Oligomer-Induced Plasticity Deficit in Hippocampal CA1 Pyramidal Neurons
Kumar Krishna et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
The utilisation of operant delayed matching and non-matching to position for probing cognitive flexibility and working memory in mouse models of Huntington's disease
Emma Yhnell et al.
JOURNAL OF NEUROSCIENCE METHODS (2016)
The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice
Haiqun Jia et al.
PLOS ONE (2016)
A Longitudinal Motor Characterisation of the Hdh(Q111) Mouse Model of Huntington's Disease
Emma Yhnell et al.
JOURNAL OF HUNTINGTONS DISEASE (2016)
Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease
Flavia Niccolini et al.
BRAIN (2015)
A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington's disease
Mar Puigdellivol et al.
HUMAN MOLECULAR GENETICS (2015)
Histone Deacetylase Inhibition via RGFP966 Releases the Brakes on Sensory Cortical Plasticity and the Specificity of Memory Formation
Kasia M. Bieszczad et al.
JOURNAL OF NEUROSCIENCE (2015)
Age-, tissue- and length-dependent bidirectional somatic CAG•CTG repeat instability in an allelic series of R6/2 Huntington disease mice
Eloise Larson et al.
NEUROBIOLOGY OF DISEASE (2015)
Histone deacetylase 3 inhibition re-establishes synaptic tagging and capture in aging through the activation of nuclear factor kappa B
Mahima Sharma et al.
SCIENTIFIC REPORTS (2015)
Suppression of Somatic Expansion Delays the Onset of Pathophysiology in a Mouse Model of Huntington's Disease
Helen Budworth et al.
PLOS GENETICS (2015)
HDAC inhibition imparts beneficial transgenerational effects in Huntington's disease mice via altered DNA and histone methylation
Haiqun Jia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Neurotrophin receptor p75NTR mediates Huntington's disease-associated synaptic and memory dysfunction
Veronica Brito et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Crtc1 Activates a Transcriptional Program Deregulated at Early Alzheimer's Disease-Related Stages
Arnaldo Parra-Damas et al.
JOURNAL OF NEUROSCIENCE (2014)
Onset of Huntington's Disease: Can It Be Purely Cognitive?
Jane S. Paulsen et al.
MOVEMENT DISORDERS (2014)
Cognitive deficits in animal models of basal ganglia disorders
Simon P. Brooks et al.
BRAIN RESEARCH BULLETIN (2013)
PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model
Albert Giralt et al.
HIPPOCAMPUS (2013)
Disassociation of Histone Deacetylase-3 from Normal Huntingtin Underlies Mutant Huntingtin Neurotoxicity
Farah H. Bardai et al.
JOURNAL OF NEUROSCIENCE (2013)
Increased 5-Methylcytosine and Decreased 5-Hydroxymethylcytosine Levels are Associated with Reduced Striatal A2AR Levels in Huntington's Disease
Izaskun Villar-Menendez et al.
NEUROMOLECULAR MEDICINE (2013)
Induction of DARPP-32 by Brain-Derived Neurotrophic Factor in Striatal Neurons In Vitro Is Modified by Histone Deacetylase Inhibitors and Nab2
Samira Chandwani et al.
PLOS ONE (2013)
HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner
Melissa Malvaez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
MSH3 Polymorphisms and Protein Levels Affect CAG Repeat Instability in Huntington's Disease Mice
Stephanie Tome et al.
PLOS GENETICS (2013)
Protein aggregates in Huntington's disease
Montserrat Arrasate et al.
EXPERIMENTAL NEUROLOGY (2012)
Long-term memory deficits in Huntingtons disease are associated with reduced CBP histone acetylase activity
A. Giralt et al.
HUMAN MOLECULAR GENETICS (2012)
Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntingtons disease mice: implications for the ubiquitinproteasomal and autophagy systems
Haiqun Jia et al.
HUMAN MOLECULAR GENETICS (2012)
Identification of Novel Potentially Toxic Oligomers Formed in Vitro from Mammalian-derived Expanded huntingtin Exon-1 Protein
Leslie G. Nucifora et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease
Haiqun Jia et al.
NEUROBIOLOGY OF DISEASE (2012)
MutSβ and histone deacetylase complexes promote expansions of trinucleotide repeats in human cells
Anne-Marie M. Gannon et al.
NUCLEIC ACIDS RESEARCH (2012)
Targeting of XJB-5-131 to Mitochondria Suppresses Oxidative DNA Damage and Motor Decline in a Mouse Model of Huntington's Disease
Zhiyin Xun et al.
CELL REPORTS (2012)
HDAC3 Is a Critical Negative Regulator of Long-Term Memory Formation
Susan C. McQuown et al.
JOURNAL OF NEUROSCIENCE (2011)
HA novel approach to investigate tissue-specific trinucleotide repeat instability
Jong-Min Lee et al.
BMC SYSTEMS BIOLOGY (2010)
Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset
Meera Swami et al.
HUMAN MOLECULAR GENETICS (2009)
Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes
Ella Dragileva et al.
NEUROBIOLOGY OF DISEASE (2009)
DNA instability in postmitotic neurons
Roman Gonitel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice
Elizabeth A. Thomas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB: CBP-dependent transcriptional activation
Christopher G. Vecsey et al.
JOURNAL OF NEUROSCIENCE (2007)
Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain
Peggy F. Shelbourne et al.
HUMAN MOLECULAR GENETICS (2007)
Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2
Serge Gregoire et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Aggregation of Expanded Huntingtin in the Brains of Patients With Huntington Disease
Guylaine Hoffner et al.
PRION (2007)
Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice
Alejandro Lloret et al.
HUMAN MOLECULAR GENETICS (2006)
Differential role for CBP and p300 CREB-binding domain in motor skill learning
Ana M. M. Oliveira et al.
BEHAVIORAL NEUROSCIENCE (2006)
Msh3 is a limiting factor in the formation of intergenerational CTG expansions in DM1 transgenic mice
L Foiry et al.
HUMAN GENETICS (2006)
Histone deacetylase 3 binds to and regulates the GCMa transcription factor
HC Chuang et al.
NUCLEIC ACIDS RESEARCH (2006)
Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington's disease mice
NK Mazarakis et al.
JOURNAL OF NEUROSCIENCE (2005)
Impaired learning-dependent cortical plasticity in Huntington's disease transgenic mice
A Cybulska-Klosowicz et al.
NEUROBIOLOGY OF DISEASE (2004)
Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice:: A model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration
JM Alarcón et al.
NEURON (2004)
Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms
ALO Hebb et al.
NEUROSCIENCE (2004)
Huntingtin and the molecular pathogenesis of Huntington's disease - Fourth in molecular medicine review series
C Landles et al.
EMBO REPORTS (2004)
Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis
L Kennedy et al.
HUMAN MOLECULAR GENETICS (2003)
Transcriptional abnormalities in Huntington disease
KL Sugars et al.
TRENDS IN GENETICS (2003)
Mismatch repair gene Msh2 modifies the timing of early disease in HdhQ111 striatum
VC Wheeler et al.
HUMAN MOLECULAR GENETICS (2003)
Trinucleotide expansion in haploid germ cells by gap repair
IV Kovtun et al.
NATURE GENETICS (2001)
Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
FC Nucifora et al.
SCIENCE (2001)
N-acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice
A van Dellen et al.
NEUROREPORT (2000)
Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells
F Trettel et al.
HUMAN MOLECULAR GENETICS (2000)
Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?
L Kennedy et al.
HUMAN MOLECULAR GENETICS (2000)
Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits
AD Lawrence et al.
BRAIN (2000)
Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
JA Bibb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
CREB-binding protein sequestration by expanded polyglutamine
A McCampbell et al.
HUMAN MOLECULAR GENETICS (2000)
Impaired planning but intact decision making in early Huntington's disease: implications for specific fronto-striatal pathology
LHA Watkins et al.
NEUROPSYCHOLOGIA (2000)
The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease
M Glass et al.
NEUROSCIENCE (2000)
分享论文
